Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Oncology·MeSH: Multiple Myeloma
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| gamunex-c | Grifols S.A. (GRFS) |
Frequently asked questions
How many drugs are in development for Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma?
BioSniper tracks 1 drug in development for Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma across 1 company.
How many clinical trials target Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma?
There are 1 clinical trial targeting Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma tracked by BioSniper.
Deep-dive into Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis